Skip to main content
Premium Trial:

Request an Annual Quote

NIAMS to Fund GWA Studies for Arthritis, Muscle and Skin Diseases

NEW YORK (GenomeWeb News) – The National Institutes of Health plans to fund genome-wide association studies with around $1 million each year over three years that will advance the understanding of arthritis, musculoskeletal diseases, and skin diseases.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases will offer between two and four projects with up to $200,000 per year for up to two years during 2009, 2010, and 2011, NIH said today.  

The studies will use existing genetic and clinical data, such as that available in the NIH’s database of Genotype and Phenotype or in other similar data sources, and will not require genotyping of samples, or recruitment or clinical characterization of subjects.

Because these studies will not involve use of subjects or genotyping, NIAMS said, these programs may be completed at modest expense and within two years.

The grants under the Genome-Wide Association Analysis of Existing Data Sets for Arthritis and Musculoskeletal and Skin Diseases will provide support for personnel, data storage and computation, travel, and other costs, NIH said.  

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.